# High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia

> **NCT06959147** · PHASE4 · RECRUITING · sponsor: **Shirong Tan** · enrollment: 46 (estimated)

## Conditions studied

- Herpes Zoster Pain
- Neuralgia, Postherpetic

## Interventions

- **DRUG:** High-Voltage Long-Duration Pulsed Radiofrequency plus Liposomal Bupivacaine group
- **OTHER:** High-Voltage Long-Duration Pulsed Radiofrequency

## Key facts

- **NCT ID:** NCT06959147
- **Lead sponsor:** Shirong Tan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-17
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06959147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06959147, "High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06959147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*